SEARCH RESULT

Total Matching Records found : 9940

Cash transfer put off by at least 3 months -Subodh Ghildiyal & Mahendra Singh

-The Times of India The expansion of UPA's flagship intervention - direct benefits transfer (DBT) - is likely to be pushed back by three months, shrinking the window for fullscale implementation of the scheme that Congress sees as its trump card for the 2014 polls. The scheme to ensure delivery of cash subsidies and entitlements to bank accounts of beneficiaries was launched in January 2013. However, for the scheme to live up...

More »

CAG report puts Delhi government hospitals in a dock

-PTI The condition of government hospitals in Delhi drew a sharp criticism from Comptroller and Auditor General (CAG), which, in its report found several glaring shortcomings like unavailability of blood banks in five hospitals. The CAG today painted a sorry state of affairs at government hospitals in the national capital in its report for the fiscal year ending March 2012, which was tabled in Delhi Assembly. The government auditor said that scrutiny of...

More »

YK Sapru, founder chairperson of Cancer Patients Aid Association (CPAA) interviewed by Sushmi Dey

-The Business Standard Interview with Founder chairman of Cancer Patients Aid Association Though the legal battle over Glivec's patentability may be over for now, Y K Sapru, the man spearheading the fight against Swiss multinational Novartis, isn't resting. Sapru, founder chairman of Cancer Patients Aid Association, or CPAA (which moved the Supreme Court to keep the prices of the cancer drug low), tells Sushmi Dey what the judgment means to cancer patients....

More »

Domestic firms rejoicing on Glivec verdict-Sushmi Dey

-The Business Standard Now, local firms can sell their low-priced generic version of the drug in India and export it to developing markets, where it is not patented Domestic drug firms such as Cipla, Natco, Ranbaxy and Hetero are a happier lot following the Supreme Court verdict on Monday, dismissing Novartis AG's patent plea for anti-cancer drug imatinib mesylate or Glivec, as sold by the Swiss drug maker. This is because the judgement...

More »

CAG blasts Narendra Modi govt for causing Rs 17,000 cr loss to Gujarat

-The Indian Express The CAG (Comptroller and Auditor General) has slammed the Gujarat Chief Minister Narendra Modi's government for causing a loss to the exchequer to the tune of Rs 17,000 cr. In its report for 2009-10 and 2010-11, placed before the Gujarat Legislative Assembly, CAG said corruption and irregularities have caused huge losses to the state. CAG blasted the Narendra Modi government for not being able to stop these irregularities. Narendra Modi has...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close